"
Tyrosine Kinase Inhibitors against Cancer: Their Safety in 216 Moroccan Patients"
written by Lamyae Nouiakh, Karima Oualla, Imane Ouafki, Soumia Berrad, Hayat Erraichi, Lamiae Amaadour, Zineb Benbrahim, Samia Arifi, Nawfel Mellas,
published by
Journal of Cancer Therapy,
Vol.12 No.3, 2021
has been cited by the following article(s):
|
[1]
|
Potency and Safety of
KRAS
G12C Inhibitors in Solid Tumors: A Systematic Review
Clinical Medicine Insights: Oncology,
2025
DOI:10.1177/11795549251331759
|
|
|
|
|
[2]
|
Beyond the Basics: Exploring Pharmacokinetic Interactions and Safety in Tyrosine-Kinase Inhibitor Oral Therapy for Solid Tumors
Pharmaceuticals,
2025
DOI:10.3390/ph18070959
|
|
|
|